Drugs / Effexor XR
Regulatory milestones approvals, filings & regulatory actions · 8 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (7) | US (FDA) | EFFEXOR XR | — | 1999-03-11 – 2007-12-14 | fda.gov ↗ |
| Approved | US (FDA) | EFFEXOR XR | — | 1997-10-20 | fda.gov ↗ |
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT00225524 | Sep 2004 → ? | depressive disorder | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00225511 | Jun 2004 → ? | depressive disorder | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 3 | NCT00225485 | Dec 2003 → ? | major depressive disorder | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00878748 | Apr 2009 → Oct 2011 | major depressive disorder | Wyeth is now a wholly owned subsidiary of Pfizer | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Effexor XR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00878748 ↗ |